Evidence map›Paper›PMID 28431556›Full record

ArticleAIDS research and therapy2017

Factors associated with loss to follow-up after occupational HIV exposure in Cape Town, South Africa: a retrospective cohort study.

Nectarios Sophocles Papavarnavas, Kathryn Manning, Fahd Conrad, Milah Govender, Gary Maartens

Abstract read
In one paragraph

Article in AIDS research and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nectarios Sophocles PapavarnavasDepartment of Medicine, Old Main Building, J-Floor, Groote Schuur Hospital, University of Cape Town, Observatory, Cape Town, 7925, South Africa.
Kathryn ManningDepartment of Medicine, Old Main Building, J-Floor, Groote Schuur Hospital, University of Cape Town, Observatory, Cape Town, 7925, South Africa.
Fahd ConradTrauma and Emergency Unit, Floor E11A, Management Suite, Groote Schuur Hospital, Main Road, Observatory, Cape Town, 7925, South Africa.
Milah GovenderQuality and Safety Unit, Groote Schuur Hospital, Main Road, Observatory, Cape Town, 7925, South Africa.
Gary MaartensDivision of Clinical Pharmacology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, 7925, South Africa. gary.maartens@uct.ac.za.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is limited data on factors associated with loss to follow-up (LTFU) of health care workers (HCWs) following occupational exposure to HIV, and most studies were conducted in an era when poorly tolerated antiretrovirals like zidovudine were used.

methodsA retrospective cohort study was conducted of HCWs attending a referral hospital's Occupational Health Clinic in Cape Town, South Africa for post-exposure prophylaxis (PEP) during a period when tenofovir was available. Our primary outcome was LTFU at the 3-month visit. We selected seven variables a priori for our logistic regression model and ensured there were at least 10 outcome events per variable to minimize bias.

resultsTwo hundred and ninety-three folders were evaluated for descriptive analysis. LTFU worsened with successive visits: 36% at 6 weeks, 60% at 3 months, and 72% at 6 months. In multivariate analysis at the 3-month visit LTFU was associated with age (adjusted odds ratio (aOR), 0.6 per 10-year increase [95% CI, 0.5-0.9]), HCW category of doctor (aOR 2.7 [95% CI, 1.3-5.5]), and time from exposure to receiving PEP of more than 24 h (aOR 5.9 [95% CI, 1.3-26.9]).

conclusionWe identified factors associated with LTFU of HCWs after occupational HIV exposure, which could be used to target interventions to improve follow-up.

Indexed as

Health PersonnelInfectious Disease Transmission, Patient-to-ProfessionalLost to Follow-UpOccupational ExposureAdultAnti-HIV AgentsEmtricitabineFemaleHIV InfectionsHumansLamivudineMalePost-Exposure ProphylaxisRetrospective StudiesSouth AfricaStavudineAnti-HIV AgentsEmtricitabineLamivudineStavudineTenofovirZidovudineHealth care workersHIVLoss to follow-upPost exposure prophylaxis

Identifiers

PMID28431556
PMCPMC5401471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.